Background: Cognitive behavioral therapy (CBT) may be useful for improving the health-
Introduction
Inflammatory bowel disease (IBD), which includes Crohn's disease (CD) and ulcerative colitis (UC), is a chronic relapsing-remitting condition with a range of symptoms including diarrhea, rectal bleeding, abdominal pain, and extra-intestinal symptoms (e.g., arthritis, liver symptoms, skin and eye manifestations) 1 . IBD patients suffer from an impaired healthrelated quality of life (HRQOL) 2, 3 and have an increased susceptibility to anxiety and depression 2, 4 .
Psychotherapy, especially cognitive behavioral therapy (CBT) where people are taught to identify and modify unhelpful thinking styles and maladaptive behaviors [5] [6] [7] , may be a useful intervention for at least some IBD patients, especially those with psychiatric comorbidities 2, 8, 9 . CBT is based on the premise that altering maladaptive thoughts results in changes in both emotions and behavior 10 . Psychotherapy may improve HRQOL 11, 12 for IBD patients but not all studies have reported psychotherapy to improve HRQOL 13, 14 . However, these studies were highly heterogeneous in terms of interventions, study populations, and measures of HRQOL which will have contributed to the inconsistent findings. The one study to have used CBT and have HRQOL as an outcome variable showed the intervention to improve inflammatory bowel disease questionnaire (IBDQ) scores compared to treatment as usual (TAU) 15 . There are barriers to the implementation of psychotherapy, such as time and travel burden for patients to attend face-to-face sessions, shortages of adequately trained therapists, high costs, potential stigma associated with seeking professional help and lack of accessibility in remote areas [16] [17] [18] [19] . These limitations may be overcome by the utilization of computerized interventions like computerized CBT (CCBT), which is CBT that is selfdirected (i.e. not facilitated by a therapist) and implemented via a computer 20, 21 .
When asked to choose between psychological interventions, a majority of IBD patients expressed a preference for a computerized over face-to-face interventioninterventions (broadly defined) have shown promise in terms of improving HRQOL in gastrointestinal conditions 23 . Computerized psychotherapy may be as effective as traditional psychotherapy 24 .
There are a number of different mechanisms by which CCBT can have its effect on HRQOL, anxiety, and depression. These include improved coping strategies, and decreased perceived stress and IBD symptoms. Coping strategies, which are specific methods for responding to stressors, can be adaptive (i.e. improve outcomes) or maladaptive (i.e. worsen outcomes) 25 ;
CCBT should aim to increase adaptive and decrease maladaptive coping strategies. Perceived stress measures the extent to which people appraise situations or events as "unpredictable, uncontrollable, and overloading" 26 ; CCBT should ultimately lead to decreased perceived stress through improving the participant's response to stress. Finally, IBD symptoms are the strictly physical manifestations of IBD as measured by brief IBD symptom questionnaires 27, 28 ; a cognitive behavioral approach may improve symptoms in IBD patients 15 .
This paper describes a randomized controlled trial (RCT) of a self-administered CCBT intervention for IBD patients focused on improving HRQOL via better management of stress and improved coping with IBD. The comparison condition is TAU which is normal medical treatment. It is hypothesized that CCBT completers will have an improved HRQOL, anxiety, depression, coping strategies, perceived stress, and IBD symptoms relative to people not allocated to the CCBT.
Materials and Methods

Trial design
This study was a multicenter (i.e. Christchurch, West Coast, and Nelson) RCT of CCBT in addition to usual therapy in adults with IBD, with parallel groups, without blinding and with imbalanced randomization. No changes to the trial design occurred during the course of the study.
Participants
Inclusion/Exclusion Criteria
Eligible patients were all adults with IBD aged 18-65, computer literate, and had access to a computer and the internet. Participants were excluded if their disease was too severe (e.g., recent major surgery and/or complicated disease). Participants had to (a) have sufficient knowledge of English to answer the questionnaires and participate in the intervention and (b) be willing to participate in the intervention and answer the questionnaires at baseline, postintervention (twelve weeks after baseline) and six months after baseline. Patients who had an existing psychotic disorder or were currently receiving any form of psychological intervention (i.e. presently receiving CBT or another therapy from a psychologist or counsellor), or were alcohol or substance dependent were excluded. Those with an ileostomy or colostomy were excluded from the study because the primary outcome measure, namely IBDQ, is not designed for those with an ileostomy or colostomy. Gastroenterologists' private clinics; and an existing database from two previous observational studies 22, 29 which were unrelated to this RCT.
Recruitment Methods and Study Settings
Most study participants were recruited from Christchurch, New Zealand. If they were interested and eligible, they were approached by the principle investigator and given an information sheet and consent form. Those who opted out were not contacted further and those who did not respond within four weeks were contacted up to three times via two different methods (phone, text message, email or letter).
Interventions
After their consent was obtained, participants were randomized to CCBT or TAU. Those who were allocated to the CCBT group were shown how to login and use the CCBT website; they received a username and password. Once the induction was completed, all participants in both groups were sent a link to the questionnaires via email. All patients in the TAU group were aware of the CCBT patients receiving the CCBT (i.e. no blinding).
Those in the CCBT group received self-administered CCBT in addition to TAU. Those in the TAU group received only usual IBD treatment which is treatment from their physician exactly as they had received previous to the study; they were not referred for mental health intervention. Both groups completed questionnaires at baseline, twelve weeks after baseline, and six months after baseline. The CCBT was implemented using MedMoodle 30 . The CCBT involved eight sessions with sixty-two resources (see Supplementary Table 1 
Outcomes
The timing of all assessments is shown in Supplementary Table 2. Outcomes were assessed by validated questionnaires as described below.
Primary
The primary outcome was IBD-specific HRQOL at twelve weeks as assessed by the IBDQ 31 , which contains thirty-two items divided in to four health sub-dimensions: bowel symptoms (e.g., loose stools, abdominal pain; ten items), systemic symptoms (e.g., fatigue, sleeping problems; five items), social functioning (e.g., limited social activity, school or work attendance; five items), and emotional functioning (e.g., irritability, anger, depression; twelve items). Responses are scored on a seven point Likert scale where higher scores indicate a better HRQOL. The IBDQ is reliable and valid 32 , has a range of 32 to 224 33 , and has a minimum clinically significant change score of twenty points 34 .
Secondary
Generic HRQOL was measured with the Short Form 12 (SF-12) and contains twelve questions 35 . Answers are scored and totaled to produce raw scale scores for a mental and physical subscale which are then transformed to a 0 -100 scale 36 . These scores have a mean of fifty and standard deviation (SD) of tenAnxiety and depression were assessed with the Hospital Anxiety and Depression Scale (HADS) 38 . It is designed to be used in a hospital context as it omits questions related to symptoms that may be caused by physical illness (e.g. dizziness) concentrating on psychological aspects of anxiety and depression. Sensitivity and specificity are optimum when caseness is defined at eight or above for the anxiety and depression subscales 39 . The HADS has been used extensively in IBD studies [40] [41] [42] .
Stress was measured with the Perceived Stress Scale (PSS). This is the most commonly used measure of the perception of stress 26 . There is a fourteen item, ten item and four item version 26, 43 . The ten item version (PSS-10) was used for this study. The items are answered on a five point Likert scale with higher scores reflecting a greater extent to which situations in a person's life are interpreted as being stressful 26, 43 . Higher PSS scores have been associated with smoking status, colds, and other stress measures 43 .
Social functioning was measured with the Social Functioning Questionnaire (SFQ) which is an eight item questionnaire 44 . The questions are answered on a scale of zero to three and a score of ten or more indicates poor social functioning 44 .
Neuroticism was measured with the Eysenck Personality Questionnaire-Brief Version (EPQ-BV) which is used to measure extraversion and neuroticism 45 . This study omitted the extraversion subscale.
The Brief Coping Operations Preference Enquiry (Brief COPE) was used to measure coping strategies 46 . It is a validated twenty-eight item questionnaire used to assess coping behaviors known to be adaptive and maladaptive strategies. There are fourteen subscales with two items each. The coping strategies are adaptive problem-focused (use of instrument support, planning, and active coping), adaptive emotion-focused (use of emotional support, religion, positive reframing, acceptance, and humor), and maladaptive (behavioral disengagement, denial, self-distraction, self-blame, substance use, and venting) coping strategies 47 .
The Harvey Bradshaw Index (HBI) was used to measure IBD-related symptoms in CD patients 27 and the Simple Clinical Colitis Activity Index (SCCAI) was used to measure symptoms in UC and inflammatory bowel disease-unspecified patients 28 .
CCBT usage and acceptability
Use of the program for each participant was measured by monitoring the number of logins and resources used by each participant. There were sixty-two resources available for download over eight sessions. People who downloaded half or more of the resources were considered to be "completers".
CCBT acceptability was determined using a ten item questionnaire designed by the authors.
Questions were asked about participant enjoyment, the relevance of the program to them, whether it improved their understanding of IBD, whether it improved their psychological or physical health, and whether they would recommend such a program to others with gastrointestinal disorders.
Sample size
Power calculation was conducted on a per-protocol (PP), not intention-to-treat (ITT), basis. It was calculated that two hundred and thirty eight participants would need to be allocated at a ratio of nine-to-eight to the CCBT versus TAU group because more CCBT participants were expected to drop out from the study. This was based on 80% power (p-value 0.05) and the CCBT group (n = 126) having an IBDQ increase of twenty more points (which is the minimum clinical significance
Randomization
This study was an open label RCT with imbalanced randomization (9 CCBT: 8 TAU).
Randomization to CCBT or TAU took place after screening and consent. An excel spreadsheet with 238 numbers randomly allocated to CCBT or TAU at a ratio of nine-to-eight was used and a number between one and 238 was produced by the website random.org 48 .
The participants were allocated in groups of six to nineteen (depending on how many were recruited in the fortnight). Allocation concealment was not used but participants were present when they were randomized so they could see how they were allocated to the CCBT or TAU group.
Participant contact via email, text message, and phone call
All participants (CCBT and TAU) were contacted via email to complete the questionnaires.
They were text messaged if they did not complete the questionnaire and were then contacted via phone call if they still had not completed the questionnaire.
In addition, participants in the CCBT group were emailed once per week for eight weeks to remind them of the availability of the program and that the next topic was released. CCBT participants were also text messaged at six weeks to encourage them to keep looking at the program and to contact the lead investigator if they had any questions. 49 was used to perform the statistical analyses. There were two populations analyzed for the CCBT group. The first was the ITT population who were participants randomized into the trial; incomplete data was replaced by using last observation carried forward. The second was the PP population who were participants who completed the protocol (i.e. completed >50% of the resources) and completed the baseline and follow-up assessments.
Statistical methods
SPSS 22-x
The primary outcome was the PP comparison of IBDQ change scores for CCBT completers versus TAU participants. Linear mixed effects models were performed for all variables with the change in the outcome as the dependent, CCBT completers versus TAU as the fixed factor and baseline outcome scores as the covariates. ITT analyses were performed last; only the primary outcome (IBDQ) and any measures which were significant in the PP analyses had ITT analyses performed. Attrition rates for the groups and the binary outcome of improvement of IBDQ score (improvers defined as change of >20 vs. non-improvers) were compared with the Fisher's exact test (two tailed).
Among CCBT participants, binary logistic regressions were performed to determine the predictors for completing the program (i.e. completing >50% of the resources); unadjusted odds ratios were calculated for each of the predictors before a multivariate model was built.
Incomplete data
All questions had a "Decline to answer" option which meant some questionnaires were not fully completed. When a subscale of a questionnaire had one answer or 10% or less of answers missing, missing or "Decline to answer" answers were replaced with means for the answers on the other questions for that subscale. In cases where more than one answer and more than 10% of answers for a questionnaire were omitted by a participant, the questionnaire was treated as missing for that participant.
Ethical Considerations
The study was conducted with the consent of the New Zealand Health and Disability Ethics 
Results
Participant Flow
The participant flow is shown in Figure 1 . Of the 231 randomized participants, thirty-two patients were excluded after randomization as they did not complete the baseline questionnaire. One hundred of the CCBT participants (88.5%) logged in at least once and twenty-nine (25.7%) of CCBT participants were "completers".
Recruitment Issues
Participants were recruited between 22 October, 2012 and 8 October, 2013. The first patient was recruited on 22 October, 2012 and the last patient had their six month follow up performed on 8 April, 2014. Recruitment was ceased short of the power calculation of 238 as it became apparent that the number of dropouts in the CCBT group had been significantly underestimated; it was expected 80% would complete the intervention but 26% did.
Baseline data
Baseline data for the CCBT and TAU groups are shown in Table 1 and Table 2 .
Attrition
At baseline, 113 CCBT and eighty-six TAU participants completed the questionnaires.
However at twelve weeks only sixty-five CCBT (57.5%) participants completed the primary outcome questionnaire (IBDQ) whereas seventy-eight TAU (90.7%) did so. Among CCBT completers, 24/29 (82.8%) completed the week twelve questionnaires. Drop out in the ITT CCBT for the week twelve questionnaires was significantly higher than in the TAU group (42.5% v. 9.3%, p = 0.048), whereas CCBT completers were no more likely to drop out than TAU participants (17.2% v. 9.3%, p = 0.87). 
Outcomes and estimation
Per-protocol outcomes Table 3 shows PP at twelve weeks and six months. 
Binary outcomes
When the analysis was performed using IBDQ as a binary outcome, at twelve weeks, 45.8%
of CCBT completers improved versus 24.4% of TAU participants and this was not significant 
Ancillary analyses
Completion of program
Of the 113 people given access to the CCBT, 100 (88.5%) people downloaded at least one of the sixty-two resources. Twenty-nine (25.7%) completed the intervention. Univariate and multivariate analyses were carried out to determine predictors of study completion (Table 4): biological treatment and baseline depression significantly reduced the odds of completion while currently using prednisone and having an IBDQ score of above 160 increased the odds of completion. A multivariate model with biological treatment, baseline depression, and IBDQ score of above 160 was performed. In this model, none of the predictors were significant.
Patient perceptions of the program
Forty participants (22 completers) completed the questionnaires about their perceptions of the program (35.4%). The majority enjoyed the program (74%), felt it had relevance (87%), felt it improved their understanding of IBD (80%), felt it improved their physical and/or mental health (74%), and would recommend it to others with gastrointestinal disorders (80%).
Discussion
The primary aim of this study was to determine if CCBT significantly increases IBDQ scores in CCBT completers compared with TAU at twelve weeks after baseline. The primary hypothesis was supported in PP analyses although change in IBDQ scores did not differ between the groups in ITT analyses. The clinical significance of this is that those who complete at least 50% of the CCBT have an improvement of HRQOL. At twelve weeks, the mean SF-12 mental score increased more in CCBT completers than TAU participants. At six months, religion decreased in TAU compared to CCBT completers, substance use decreased in CCBT completers compared to TAU participants, and venting increased in CCBT completers compared to TAU participants. Only religion change scores remained significant in ITT analyses.
The predictors of non-completion of CCBT were biological treatment (i.e. infliximab or adalimumab), depression, low IBDQ score, or not using prednisone at baseline. Generally, patients with more severe depression at baseline have a less favorable response to psychotherapy 50, 51 and there is poor adherence with medication among psychologically distressed people with IBD [52] [53] [54] . Moreover, an IBS study reported that HRQOL was more impaired in dropouts than treatment completers 55 , which is similar to what was found in this study. Severe disease (as indicated by low IBDQ scores) predicted dropout in this study and so it is consistent that those on biological treatment dropped out more because biological treatment is given to those with more severe and refractory disease 56 . On the other hand, the phenomenon of those on prednisone at baseline being less likely to drop out is more difficult to explain. Of note was that a relatively small percentage of the total sample was on biological treatment and prednisone and the mean dose of prednisone was low.
The CCBT did not improve social functioning, perceived stress, or IBD symptoms.
Nevertheless, most people who completed the acceptability questionnaire reported that the CCBT was enjoyable, relevant, improved understanding of IBD, improved physical and/or mental health, and would recommend the program to other people with IBD or other gastrointestinal disorders.
Also, the open-ended qualitative answers were generally positive about the CCBT.
Implications
Overall, the findings were modest although promising in the short term among those who completed the CCBT. There is an unfortunate paradox with the prediction of completion of the CCBT: those who may benefit most from CCBT, namely those who experience psychological distress, are less likely to complete the intervention. Given that the effect of depression was not significant in the multivariate model (once baseline IBDQ scores and biological use were controlled for) suggests that the effect of depression is confounded by disease severity. Therefore, treating the disease itself is probably one of the most effective ways of treating the psychiatric morbidity associated with IBD.
Some participants reported positive benefits from the CCBT, including an increase in their knowledge of their disease. There were no reported harms from this cheap intervention and so it is possible this program can be made available to many IBD patients via Crohn's and
Colitis websites in North America, Australasia, and Europe. At the very least, it provides a good basis for providing constructive information to IBD patients.
Limitations and future directions
There was no sham treatment and so participants were not blinded to whether they were receiving the treatment or not. Blinding was not seen as practical or worthwhile because the main aim was to see if the CCBT is better than the status quo. Blinding would not have improved the results in favor of the CCBT.
This study did not reach the numbers calculated in the power calculation. Nevertheless, 199
randomized participants is a significant number in a study of this nature and this is one of the largest CCBT studies in physically ill patients to date 21 .
The low adherence was of concern. Part of the reason for the modest adherence in the present study may have been that the website used was not as modern and user-friendly as other similar websites, such as one for depression 57 . Nevertheless, it is common for CCBT studies to have high dropout rates, especially when there is no therapist contact 58, 59 . For example, arguably the strongest RCT ever performed in CCBT for chronic physical illnesses was in patients with diabetes and reported only fifty-three out of 125 (42.4%) CCBT participants completed all sessions 60 . Indeed, the participants in the present study anecdotally reported the CCBT was demanding and time consuming and it has been reported in a systematic review that dropout is more common as treatment length increases 61 . Overall, attempts can be made to improve adherence through more human contact, less sessions, or a better website, but it is also possible modest adherence may be inevitable in CCBT studies irrespective of the quality of the website or therapist contact. Furthermore, increased human contact would decrease cost-effectiveness and the intervention in this study is already average in length in the context of CCBT studies 21 .
The high dropout, which is commonplace in such studies as this one 23 , has an important implication: the PP analyses were highly susceptible to self-selection biases. Nevertheless, ITT analyses were performed in an attempt to detect treatment effects not caused by selfselection. It cannot be expected that participants who do not utilize the materials of the CCBT can gain any benefits and so the PP analyses were acceptable in this context. Again, future research should focus on increasing treatment adherence.
There was an initial improvement in IBDQ scores among CCBT completers but these positive effects were not maintained at six months. If there are no long terms gains from the CCBT, the CCBT may not be of use beyond the time at which the participants participate in it. Future research needs to attempt to address this through offering "booster" sessions of CCBT after it is completed. For example, booster sessions may improve long term outcomes in conventional CBT for depression 62, 63 ; future studies should explore this possibility in the context of CCBT for IBD participants.
The amount of time since diagnosis was not recorded. This is problematic because perhaps newer diagnoses are more likely to complete or benefit from CCBT. Future research should record the time since diagnosis of each patient in the CCBT study.
Finally, it was unknown whether some patients began psychiatric treatments of a medical or psychosocial nature outside the boundaries of the study. Future studies should ask the participants at twelve weeks and six months if they have started taking a new psychiatric medication or attending psychotherapy outside of the prescribed CCBT in the study since the study began.
Conclusions
This study aimed to improve the HRQOL of people who participate in a CCBT program.
There were some improvements in IBDQ scores at twelve weeks after baseline but these were not maintained at six months. The high dropout rate from the CCBT group was of concern and future research should aim to improve adherence rates. Nevertheless, the CCBT helped some participants to better understand their IBD. Therefore, this type of intervention should be further tested in subgroups which may benefit and considered further by patient organizations as a means of educating their constituents.
• Completed 12 week IBDQ (n=78). One IBDQ missing due to new stoma.
Completed 6 month questionnaires (n=53; 24 completers and 29 non completers). One IBDQ missing due to stoma.
Completed 6 month questionnaires (n=66). One IBDQ missing due to new stoma. 
